malondialdehyde has been researched along with prazosin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SN; Kim, YC; Yoon, MY | 1 |
| Cao, X; Fathallah, L; Greene, DA; Obrosova, IG; Stevens, MJ; Van Huysen, C | 1 |
| Lim, SK | 1 |
| Chen, IJ; Hsieh, SL; Kwan, AL; Lin, HL; Shen, KP; Wu, BN | 1 |
| Adamczyk-Sowa, M; Bartosz, G; Pierzchala, K; Sadowska-Bartosz, I; Sowa, P; Zwirska-Korczala, K | 1 |
| Chen, X; Han, L; Hu, Z; Li, C; Li, X; Liu, J; Wu, T; Zhao, W; Zhou, J | 1 |
6 other study(ies) available for malondialdehyde and prazosin
| Article | Year |
|---|---|
Potentiation of acetaminophen hepatotoxicity by acute physical exercise in rats.
Topics: Acetaminophen; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alanine Transaminase; Analgesics; Animals; Aspartate Aminotransferases; Dose-Response Relationship, Drug; Female; Glutathione; Lipid Peroxidation; Liver; Malondialdehyde; Physical Conditioning, Animal; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Time Factors; Vitamin E; Yohimbine | 1997 |
Evaluation of alpha(1)-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
Topics: Adrenergic alpha-Antagonists; Animals; Antioxidants; Blood Glucose; Blood Pressure; Body Weight; Creatine; Diabetes Mellitus, Experimental; Glutathione; Hexoses; Inositol; Male; Malondialdehyde; Mitochondria; NAD; Oxidative Stress; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Regional Blood Flow; Sciatic Nerve; Sodium-Potassium-Exchanging ATPase; Sorbitol; Taurine | 2000 |
Consequences of haemolysis without haptoglobin.
Topics: Aldehydes; Animals; Cysteine Proteinase Inhibitors; Diazoxide; Haptoglobins; Hemoglobins; Hemolysis; Kidney; Malondialdehyde; Mice; Mice, Knockout; Nitric Oxide; Orosomucoid; Oxidative Stress; Phenotype; Prazosin; Protein Binding; Vasodilator Agents | 2001 |
Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Atorvastatin; Blood Glucose; Body Weight; Brain; Dietary Fats; Female; Glutathione Peroxidase; Heptanoic Acids; Hyperglycemia; Hyperlipidemias; Insulin; Ketanserin; Lipid Peroxidation; Lipogenesis; Liver; Malondialdehyde; Mice; Mice, Inbred C57BL; Piperazines; PPAR gamma; Prazosin; Propranolol; Pyrroles; Superoxide Dismutase; Weight Gain | 2009 |
Role of melatonin receptor MT(2) and quinone reductase II in the regulation of the redox status of 3T3-L1 preadipocytes in vitro.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Catalase; Glutathione Peroxidase; Glutathione Reductase; Malondialdehyde; Melatonin; Mice; Oxidation-Reduction; Oxidative Stress; Prazosin; Quinone Reductases; Receptor, Melatonin, MT2; Superoxide Dismutase; Tryptamines | 2013 |
Terazosin Stimulates Pgk1 to Remedy Gastrointestinal Disorders.
Topics: Apoptosis; Caco-2 Cells; Cell Survival; Colitis; Cytokines; Deoxyglucose; Dextran Sulfate; Gastric Mucosa; Gastrointestinal Diseases; Glucose; Humans; Hydrogen Peroxide; Inflammation Mediators; Lactic Acid; Malondialdehyde; Models, Biological; Peroxidase; Phosphoglycerate Kinase; Prazosin; Pyroptosis; Stomach Ulcer; Superoxide Dismutase | 2021 |